common challenges glp-1 users Exploring the Side Effects of Receptor Agonist: To Ensure Its Optimal Positioning GLP-1 CPG Consumer Trends |

The study protocol received ethical approval from the institutional review board (UPMREB CODE: 2022-0425-01)

The cohort was 78.6% female, average age 52.7 years

Krajnc N, Itariu B, Macher S, Marik W, Harreiter J, Michl M et al (2023) Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension

A controlled clinical trial revealed that patients with GLP-1ARs therapy showed significant reductions in perception of all five basic tastes, scoring 29% lower on standardized tests like the Waterless Empirical Taste Test (WETT ) compared to controls